» Articles » PMID: 29408976

Host Immune Responses to Toxoplasma Gondii

Overview
Journal Int Immunol
Date 2018 Feb 7
PMID 29408976
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Toxoplasma gondii can infect homoeothermic animals including humans and cause lethal toxoplasmosis in immunocompromised individuals. When hosts are infected with T. gondii, the cells induce immune responses against T. gondii. The pathogen infection is recognized by immune sensors that directly detect T. gondii structural components, leading to production of pro-inflammatory cytokines and chemokines. Antigen-presenting cells such as macrophages and dendritic cells strongly activate T cells and induce development of Th1 cells and antigen-specific killer CD8 T cells. These T cells and Group 1 innate lymphoid cells are main producers of IFN-γ, which robustly stimulates cell-autonomous immunity in cells infected with T. gondii. IFN-γ-inducible effectors such as IFN-inducible GTPases, inducible nitric oxide synthase and indoleamine-2,3-dioxygenase differentially play important roles in suppression of T. gondii growth and its direct killing in anti-T. gondii cell-autonomous immune responses. In this review, we will describe our current knowledge of innate, adaptive and IFN-γ-mediated cell-autonomous immunity against T. gondii infection.

Citing Articles

T-cell activation of Toxoplasma gondii positive donors by maltodextrin nanoparticles formulated with killed Toxoplasma gondii.

Vargas-Montes M, Fasquelle F, Cardona N, Gomez-Marin J, Betbeder D BMC Infect Dis. 2025; 25(1):279.

PMID: 40011842 PMC: 11866635. DOI: 10.1186/s12879-025-10656-5.


Type I TR and ROP16 Synergistically Downregulate IL-12 to Inhibit Host Reactive Oxygen Species Production.

Geng X, Li R, Du J, Zhang M, Jiang W, Sun Q Pathogens. 2025; 14(2).

PMID: 40005546 PMC: 11858468. DOI: 10.3390/pathogens14020171.


Discovery of novel vaccine candidates based on the immunogenic epitopes derived from membrane proteins.

Hosseini S, Hashemi S, Siamian D, Asghari A, Fathollahzadeh M, Majidiani H Clin Exp Vaccine Res. 2025; 14(1):86-100.

PMID: 39927227 PMC: 11799584. DOI: 10.7774/cevr.2025.14.e4.


Immunogenicity and protective efficacy of recombinant chimeric antigens based on surface proteins of .

Chyb M, Ferra B, Kawka M, Skwarecka M, Dziadek B, Gatkowska J Front Immunol. 2024; 15:1480349.

PMID: 39726608 PMC: 11670819. DOI: 10.3389/fimmu.2024.1480349.


Toxoplasma gondii-Derived Exosomes: A Potential Immunostimulant and Delivery System for Tumor Immunotherapy Superior to Toxoplasma gondii.

Zhao L, Sun Q, Wang C, Liu J, Yan X, Shao M Int J Nanomedicine. 2024; 19:12421-12438.

PMID: 39600411 PMC: 11590659. DOI: 10.2147/IJN.S483626.